SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity.
Mangaonkar AA, Lasho TL, Finke C, Ketterling RP, Reichard KK, McCullough K, Gangat N, Al-Kali A, Begna KH, Hogan WH, Litzow MR, Alkhateeb H, Shah M, Pardanani A, Tefferi A, Al Ali NH, Talati C, Sallman D, Padron E, Komrokji R, Patnaik MM.
Mangaonkar AA, et al. Among authors: mccullough k.
Haematologica. 2022 May 1;107(5):1189-1192. doi: 10.3324/haematol.2021.280463.
Haematologica. 2022.
PMID: 35142154
Free PMC article.
No abstract available.